Stay updated on Ruxolitinib for Eosinophilic Disorders Clinical Trial
Sign up to get notified when there's something new on the Ruxolitinib for Eosinophilic Disorders Clinical Trial page.

Latest updates to the Ruxolitinib for Eosinophilic Disorders Clinical Trial page
- Check3 days agoChange DetectedRecruitment status updated to Active, not recruiting, indicating no current enrollment. Stanford University is listed as sponsor and ASCO as a collaborator, and multiple principal investigator contact details were removed.SummaryDifference2%

- Check10 days agoChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6, indicating a minor update to the page's content or metadata on ClinicalTrials.gov.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page shows an updated Revision: v3.6.5, signaling a new site version. This update appears to be a backend or template change rather than a modification to the study information.SummaryDifference0.1%

- Check46 days agoChange DetectedThe revision label at the bottom of the page was updated from v3.6.3 to v3.6.4, signaling a small maintenance update rather than a substantive change to study information.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page's revision tag was updated to v3.6.3, replacing the previous v3.6.2. This reflects a new version of the page without changing the substantive study details.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2, indicating an updated release of the page. This does not modify study details or user-facing content.SummaryDifference0.1%

Stay in the know with updates to Ruxolitinib for Eosinophilic Disorders Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ruxolitinib for Eosinophilic Disorders Clinical Trial page.